Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01179477 · ClinicalTrials.gov registry record
QuickFlex Micro Left Ventricular Lead Post Approval Study
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 1,930
- Enrollment target
NCT01179477: Completed study, sponsored by Abbott Medical Devices.
NCT01179477 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,930 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01179477 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 1,930 participants
- Enrollment target
Study Summary
The purpose of this multicenter post-approval study is to evaluate the acute and chronic performance of the QuickFlex® μ 1258T left ventricular (LV) lead.
Primary Outcome
Percent of Participants Alive and Without a Left Ventricular Lead-related Complication at 5 years of follow-up. Per FDA, data from IDE subjects who did not consent to rollover into the post approval study at sites participating in the post approval study, were included in this analysis (see clinical investigational protocol).
Interventions
- DEVICE Implantation of a QuickFlex® μ Model 1258T LV Lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,930 participants |
| Start Date | 2010-09 |
| Est. Completion | 2017-09 |
What the finished NCT01179477 record still lists
NCT01179477 is an observational study that tracks outcomes without assigning an intervention. Its 1,930 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Implantation of a QuickFlex® μ Model 1258T LV Lead is the first listed.
NCT01179477 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01179477 about?
NCT01179477 is a clinical study titled "QuickFlex Micro Left Ventricular Lead Post Approval Study". The purpose of this multicenter post-approval study is to evaluate the acute and chronic performance of the QuickFlex® μ 1258T left ventricular (LV) lead.
What is the current status of trial NCT01179477?
This trial is currently completed. The enrollment target is 1,930 participants. The study started on 2010-09. Estimated completion is 2017-09.
What interventions are being tested in trial NCT01179477?
The interventions under investigation include: Implantation of a QuickFlex® μ Model 1258T LV Lead (DEVICE).
Who is sponsoring clinical trial NCT01179477?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
- NCT06058455 · 1,920 participants · NA
An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
- NCT05174169 · 1,912 participants · Phase 2
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- NCT06799117 · 1,912 participants · NA
Adaptive Decision Support for Addiction Treatment Master
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia